Atlas Trials

A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal Cancer

Clinical trial NCT07750041 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07750041
Sponsor
CSPC Megalith Biopharmaceutical Co.,Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Unresectable Advanced or Metastatic Colorectal Cancer
Start date
2026-08-30
Primary completion
2027-12-31
Enrollment
260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.